An immunochemical fecal occult blood test was specific for predicting lower gastrointestinal tract lesions but did not adequately predict lesions in the upper gastrointestinal tract. br / iMedscape Medical News/i
The aim was to assess the utility of FibroTest-ActiTest (FT-AT) as noninvasive markers of histological changes in patients with chronic hepatitis. Journal of Viral Hepatitis
U.S. drug reviewers highlighted safety issues with an experimental Merck & Co hepatitis drug, including anemia and reports of psychiatric problems, in documents released on Monday. Reuters Health Information